Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

9.010 USD -0.140 (-1.53%)
Streaming Delayed Price Updated: 11:07 AM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biocryst Pharma Inc

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
BioCryst Prices Public Offering of Common Stock
From GlobeNewswire News Releases
BioCryst Commences Public Offering of Common Stock
From GlobeNewswire News Releases
Biocryst to Present Abstracts at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology
From GlobeNewswire News Releases
BioCryst Reports Third Quarter 2019 Financial Results and Upcoming Key Milestones
From GlobeNewswire News Releases
New Clinical Trial Results and Market Research Support Significant Commercial Opportunity for Oral, Once Daily BCX7353 in HAE
From GlobeNewswire News Releases
BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
BioCryst Begins Phase 1 Trial With BCX9250, an Oral ALK-2 Inhibitor, for Treatment of Fibrodysplasia Ossificans Progressiva
From GlobeNewswire News Releases
BioCryst to Provide Commercial Update and Report Third Quarter 2019 Financial Results on November 6
From GlobeNewswire News Releases
BioCryst Reports Data From Phase 1 Trial of BCX9930 and Announces Plans to Advance Program Into Proof of Concept Study in PNH Patients
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
U.S. Government Exercises Option for Additonal Rapivab® for Strategic National Stockpile
$14 million in non-dilutive capital added by year end 
From GlobeNewswire News Releases
BioCryst Pharmaceuticals to Present at Cantor Global Healthcare Conference
From GlobeNewswire News Releases
BioCryst Appoints Helen Thackray, M.D., to Board of Directors
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
BioCryst to Present at H.C. Wainwright Global Investment Conference
From GlobeNewswire News Releases
BioCryst Reports Second Quarter 2019 Financial Results
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
From GlobeNewswire News Releases
BioCryst to Report Second Quarter 2019 Financial Results on August 6
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2019 financial results on Tuesday, August 6, 2019. 
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted three newly-hired employees options to purchase an aggregate of... 
From GlobeNewswire News Releases
BioCryst Appoints Megan Sniecinski Chief Business Officer
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Megan Sniecinski as chief business officer. 
From GlobeNewswire News Releases
Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company has begun enrollment of a Phase 1 trial of BCX9930, an oral Factor D inhibitor discovered and developed by BioCryst, for... 
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the compensation committee of BioCryst’s board of directors granted four newly-hired employees options to purchase an aggregate of... 
From GlobeNewswire News Releases
BioCryst to Present at Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the Jefferies 2019 Healthcare Conference in New York on Wednesday, June 5, 2019 at 10:30 a.m. ET and the... 
From GlobeNewswire News Releases
BioCryst’s Oral BCX7353 Meets Primary Endpoint in Phase 3 APeX-2 Trial
NDA filing on-track for Q4 2019 
From GlobeNewswire News Releases
BioCryst to Present at Bank of America Merrill Lynch Health Care Conference
BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas on Wednesday, May 15, 2019 at 1:00... 
From GlobeNewswire News Releases
BioCryst Completes Phase 1 Clinical Trial of Galidesivir
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the completion of a randomized, placebo-controlled Phase 1 clinical trial to evaluate intravenous (IV) galidesivir in healthy volunteers. In... 
From GlobeNewswire News Releases
BioCryst Reports First Quarter 2019 Financial Results
BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the first quarter ended March 31, 2019 and provided a corporate update. 
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the compensation committee of BioCryst’s board of directors granted two newly-hired employees options to purchase an aggregate of... 
From GlobeNewswire News Releases
BioCryst to Report First Quarter 2019 Financial Results on May 8
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2019 financial results on Wednesday, May 8, 2019. 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account